EP3109241B1:Method of refining valsartan comprising more than 10% d-isomers
Current Assignee:Zhejiang Huahai Pharmaceutical Co Ltd
Application EP15751399.5A events 2014-02-21 Priority to CN201410063384.1A 2015-02-15 Application filed by Zhejiang Huahai Pharmaceutical Co Ltd 2015-02-15 Priority to PCT/CN2015/073126 2016-12-28 Publication of EP3109241A1 2017-07-05 Publication of EP3109241A4 2019-04-17 Application granted 2019-04-17 Publication of EP3109241B1 2019-05-09 Application status is Active 2035-02-15 Anticipated expiration 欧盟过了缬沙坦的杂质精炼方法